0.82
price up icon0.49%   0.004
after-market 시간 외 거래: .82
loading

Enlivex Ltd 주식(ENLV)의 최신 뉴스

pulisher
Apr 15, 2026

Enlivex (ENLV) price target increased by 53.85% to 20.40 - MSN

Apr 15, 2026
pulisher
Apr 14, 2026

Enlivex Therapeutics (ENLV) price target decreased by 30.00% to 7.14 - MSN

Apr 14, 2026
pulisher
Apr 11, 2026

If You Invested $1,000 in Enlivex Ltd (ENLV) - Stock Titan

Apr 11, 2026
pulisher
Apr 10, 2026

Volume Recap: Is now the right time to enter Enlivex Therapeutics Ltd2026 Earnings Impact & Community Consensus Stock Picks - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 09, 2026

ENLV SEC FilingsEnlivex Ltd 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 09, 2026
pulisher
Apr 08, 2026

Enlivex Shares Tokenized on Ondo Global Markets to Expand Global Digital Investor Access - TipRanks

Apr 08, 2026
pulisher
Apr 08, 2026

Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares - The Manila Times

Apr 08, 2026
pulisher
Apr 08, 2026

Ondo tokenizes Enlivex (Nasdaq: ENLV) shares for global digital access - Stock Titan

Apr 08, 2026
pulisher
Apr 08, 2026

Ondo Global Markets Tokenizes Enlivex's Ordinary Shares - 富途牛牛

Apr 08, 2026
pulisher
Apr 07, 2026

Rain Crypto Jump On Red Market: Big Pharma Enlivex Raised $21M Treasury - 99Bitcoins

Apr 07, 2026
pulisher
Apr 07, 2026

ENLV Stock Rating: HC Wainwright & Co. Raises Price Target to $2 - GuruFocus

Apr 07, 2026
pulisher
Apr 06, 2026

Enlivex shares jump after earnings as treasury gains boost results - MSN

Apr 06, 2026
pulisher
Apr 04, 2026

ENLV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026
pulisher
Apr 03, 2026

ENLV PE Ratio & Valuation, Is ENLV Overvalued - Intellectia AI

Apr 03, 2026
pulisher
Apr 01, 2026

Enlivex clears pivotal FDA hurdle in knee osteoarthritis - Longevity.Technology

Apr 01, 2026
pulisher
Apr 01, 2026

Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index

Apr 01, 2026
pulisher
Apr 01, 2026

Market Wrap: What analysts say about Enlivex Therapeutics Ltd stock2026 Big Picture & Technical Entry and Exit Tips - baoquankhu1.vn

Apr 01, 2026
pulisher
Mar 28, 2026

Enlivex Therapeutics (NASDAQ:ENLV) Stock Rating Lowered by Wall Street Zen - MarketBeat

Mar 28, 2026
pulisher
Mar 27, 2026

Enlivex Announces $21M Debt Financing and Prediction Markets Treasury Expansion - Bitcoin.com News

Mar 27, 2026
pulisher
Mar 27, 2026

RAIN Token Climbs to 25th in Market Cap Following Institutional Activity and Protocol Upgrades - Bitget

Mar 27, 2026
pulisher
Mar 26, 2026

Enlivex Therapeutics Tokenized Stock (Ondo) price today, ENLVon to USD live price, marketcap and chart - CoinMarketCap

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025 - NewMediaWire

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025 | Corporate - EQS News

Mar 26, 2026
pulisher
Mar 26, 2026

Published on: 2026-03-26 22:45:56 - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Reports Full-Year 2025 Results, Profit of $1.23 Billion and Diluted Earnings per Share of $25.48 - marketscreener.com

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Posts $1.23 Billion Profit for 2025 on Treasury Asset Gains - The Globe and Mail

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Highlights Rain’s AI Agent Launch and $5 Million Grant Program to Expand Prediction Markets - tipranks.com

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt - manilatimes.net

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex (NASDAQ: ENLV) highlights Rain AI launch, $5M grants and RAIN token burn - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

One prompt can now create a live prediction market as Rain adds $5M - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Obtains $21 Million Loan to Purchase RAIN Tokens and Initiate $20 Million Buyback - Bitget

Mar 26, 2026
pulisher
Mar 25, 2026

Earnings call transcript: Enlivex Q4 2025 sees stock surge on treasury gains - Investing.com Australia

Mar 25, 2026
pulisher
Mar 25, 2026

Envilex Therapeutics (ENLV) Reports Strong FY GAAP EPS - GuruFocus

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Soars After FDA Approval for Allocetra Trial - StocksToTrade

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Stock Boosted by FDA Approval for Allocetra in Osteoarthritis Trials - timothysykes.com

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Therapeutics Q4 Earnings Call Highlights - marketbeat.com

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Allocetra Takes A Leap as FDA Clears Phase 2b Trial for Osteoarthritis - timothysykes.com

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48 - Bitget

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Secures $21 Million Convertible Debt, Expands RAIN Token Holdings and Launches $20 Million Buyback - The Globe and Mail

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Therapeutics (NASDAQ:ENLV) Releases Earnings Results, Beats Estimates By $12.88 EPS - MarketBeat

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Ltd. Reports $1.23 Billion Net Income for 2025 Driven by Treasury Asset Appreciation - Quiver Quantitative

Mar 25, 2026
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
자본화:     |  볼륨(24시간):